Big winners in 2015’s first half: Chinese and biotech ETFs
June 30, 2015 at 03:00 AM EDT
While Chinese stocks have slumped this month, they’re still leaders when it comes to year-to-date performance. Biotech funds also dominate a list of top-performing nonleveraged ETFs.